Get the Stockscreener App
125.11
0.85%
-1.07
After Hours:
125.11
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Teleflex Incorporated stock is traded at $125.11, with a volume of 596.36K.
It is down -0.85% in the last 24 hours and down -7.44% over the past month.
Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2024 sales), interventional (19%), anesthesia (13%), surgical (15%), interventional urology (11%), original-equipment manufacturing (11%), and other (7%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.
See More
Previous Close:
$126.18
Open:
$126.59
24h Volume:
596.36K
Relative Volume:
0.54
Market Cap:
$5.59B
Revenue:
$3.03B
Net Income/Loss:
$237.44M
P/E Ratio:
24.87
EPS:
5.03
Net Cash Flow:
$450.04M
1W Performance:
-1.03%
1M Performance:
-7.44%
6M Performance:
-36.02%
1Y Performance:
-38.88%
1-Day Range:
$124.36
$127.55
1-Week Range:
$120.06
$127.55
52-Week Range:
$120.06
$249.91
Teleflex Incorporated Stock (TFX) Company Profile
Name
Teleflex Incorporated
Sector
Industry
Phone
610-225-6800
Address
550 E SWEDESFORD RD, WAYNE, PA
Compare TFX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TFX
Teleflex Incorporated
|
125.11 | 5.59B | 3.03B | 237.44M | 450.04M | 5.03 |
|
ISRG
Intuitive Surgical Inc
|
536.51 | 189.75B | 8.71B | 2.48B | 1.75B | 6.82 |
|
ALC
Alcon Inc
|
95.75 | 48.62B | 9.91B | 1.02B | 665.00M | 2.05 |
|
BDX
Becton Dickinson Co
|
167.22 | 48.37B | 20.87B | 1.50B | 2.59B | 5.24 |
|
RMD
Resmed Inc
|
245.04 | 35.18B | 5.02B | 1.31B | 1.56B | 8.91 |
|
COO
The Cooper Companies, Inc.
|
82.27 | 16.46B | 3.90B | 392.30M | 288.10M | 1.95 |
Teleflex Incorporated Stock (TFX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-04-25 | Downgrade | BofA Securities | Neutral → Underperform |
| Feb-28-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Feb-28-25 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Feb-28-25 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Feb-27-25 | Downgrade | Citizens JMP | Mkt Outperform → Mkt Perform |
| Jul-01-24 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-04-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jun-21-23 | Downgrade | Needham | Buy → Hold |
| May-30-23 | Initiated | CL King | Buy |
| May-30-23 | Resumed | Morgan Stanley | Equal-Weight |
| Apr-26-23 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Oct-26-22 | Initiated | Mizuho | Neutral |
| Oct-14-22 | Resumed | Stephens | Overweight |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Jul-29-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jul-06-22 | Initiated | Wolfe Research | Outperform |
| May-09-22 | Initiated | BofA Securities | Neutral |
| Apr-13-22 | Initiated | Truist | Hold |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-04-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-10-21 | Initiated | RBC Capital Mkts | Outperform |
| Oct-07-21 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Sep-07-21 | Resumed | Raymond James | Outperform |
| Jul-19-21 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Jan-06-21 | Reiterated | Needham | Buy |
| Nov-02-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jan-31-20 | Reiterated | Needham | Buy |
| Aug-02-19 | Reiterated | Needham | Buy |
| Jun-11-19 | Initiated | Wells Fargo | Outperform |
| Apr-24-19 | Downgrade | Needham | Strong Buy → Buy |
| Feb-22-19 | Reiterated | Needham | Strong Buy |
| Oct-16-18 | Initiated | Barclays | Equal Weight |
| Sep-10-18 | Upgrade | Needham | Buy → Strong Buy |
| Aug-03-18 | Reiterated | Needham | Buy |
| May-14-18 | Reiterated | Needham | Buy |
| May-04-18 | Reiterated | Needham | Buy |
| Apr-04-18 | Initiated | Goldman | Neutral |
| Nov-10-17 | Resumed | Piper Jaffray | Overweight |
| Nov-03-17 | Reiterated | Needham | Buy |
| Sep-08-17 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
| Sep-06-17 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-06-17 | Reiterated | Needham | Buy |
| Mar-07-17 | Initiated | Needham | Buy |
| Jan-06-17 | Upgrade | Jefferies | Hold → Buy |
| Jul-12-16 | Downgrade | KeyBanc Capital Mkts | Overweight → Sector Weight |
View All
Teleflex Incorporated Stock (TFX) Latest News
Bronstein, Gewirtz & Grossman, LLC Encourages Teleflex Incorporated (TFX) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Teleflex Incorporated Investors to Inquire About Securities Class Action InvestigationTFX - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Teleflex Incorporated (TFX) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Some May Be Optimistic About Teleflex's (NYSE:TFX) Earnings - Yahoo Finance
Teleflex Investor News: Rosen Law Firm Encourages Teleflex Incorporated Investors to Inquire About Securities Class Action InvestigationTFX - marketscreener.com
Teleflex Incorporated (TFX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
2025-05-07 | Teleflex Incorporated (TFX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation | NYSE:TFX | Press Release - Stockhouse
TFX Investors Have Opportunity to Join Teleflex Incorporated Fraud Investigation with the Schall Law Firm - PR Newswire
Q1 Earnings Highlights: Teleflex (NYSE:TFX) Vs The Rest Of The Surgical Equipment & ConsumablesSpecialty Stocks - Yahoo Finance
Teleflex to Present at 2025 BofA Health Care Conference in Las Vegas - MSN
Teleflex Reports Q1 2025 Results and Revises Full-Year Guidance - MSN
Teleflex Announces FDA Clearance for Expanded Use of QuikClot Control+ Hemostatic Device - MSN
Teleflex outlines growth strategy with 6% projection for RemainCo and BIOTRONIK acquisition - MSN
Teleflex (NYSE:TFX) Price Target Cut to $137.00 by Analysts at Truist Financial - Defense World
Teleflex (NYSE:TFX) Price Target Lowered to $173.00 at Morgan Stanley - Defense World
Teleflex Incorporated Announcement: If You Have Suffered - GlobeNewswire
Teleflex Incorporated Announcement: If You Have Suffered Losses in Teleflex Incorporated (NYSE: ... - Bluefield Daily Telegraph
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Teleflex Incorporated (TFX) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
Teleflex (TFX) Stock Rating Maintained by Morgan Stanley, Price Target Lowered | TFX Stock News - GuruFocus
Teleflex Q1 Earnings Beat, '25 EPS View Down, Stock Up - TradingView
Wells Fargo & Company Issues Pessimistic Forecast for Teleflex (NYSE:TFX) Stock Price - Defense World
Bronstein, Gewirtz & Grossman, LLC Encourages Teleflex Incorporated (TFX) Investors to Inquire about Securities Investigation - Louisiana First News
Results: Teleflex Incorporated Exceeded Expectations And The Consensus Has Updated Its Estimates - Yahoo Finance
Decoding Teleflex Inc (TFX): A Strategic SWOT Insight - GuruFocus
Teleflex Incorporated Announcement: If You Have Suffered Losses in Teleflex Incorporated (NYSE: TFX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights - GlobeNewswire Inc.
Teleflex (TFX) Rating Maintained as Price Target Lowered by RBC Capital | TFX Stock News - GuruFocus
Teleflex (TFX) Price Target Adjusted by Wells Fargo | TFX Stock News - GuruFocus
Truist Securities Cuts Price Target on Teleflex to $137 From $140, Keeps Hold Rating - marketscreener.com
RBC Cuts Price Target on Teleflex to $145 From $150, Keeps Sector Perform Rating - marketscreener.com
Are Teleflex Incorporated's (NYSE:TFX) Mixed Financials Driving The Negative Sentiment? - Yahoo Finance
Teleflex (TFX) Price Target Cut by RBC Capital | TFX Stock News - GuruFocus
Teleflex Incorporated: A Year of Highs, Lows, and Market Resilience - investchronicle.com
In the Green: Teleflex Incorporated (TFX) Closes at 125.87, Up/Down -8.16 from Previous Day - DWinneX
Teleflex (TFX) Sees Price Target Reduction Amid EPS Guidance Cut | TFX Stock News - GuruFocus
Teleflex (TFX) Price Target Revised by Jefferies Amid Tariff Cha - GuruFocus
Zacks Research Estimates Teleflex’s Q4 Earnings (NYSE:TFX) - Defense World
Teleflex Reports Q1 2025 Results and Strategic Plans - TipRanks
Teleflex Investor News: Rosen Law Firm Encourages Teleflex Incor - GuruFocus
Earnings call transcript: Teleflex Q1 2025 misses EPS forecast, stock dips By Investing.com - Investing.com South Africa
Teleflex (TFX) Price Target Revised by Jefferies Amid Tariff Challenges | TFX Stock News - GuruFocus
TELEFLEX INC SEC 10-Q Report - TradingView
Press Release Distribution & PR Platform - ACCESS Newswire
Teleflex Q1 2025 Earnings: Revenue Meets Expectations Despite ChallengesNews and Statistics - IndexBox
Teleflex (NYSE:TFX) Reports Q1 In Line With Expectations - Yahoo Finance
Earnings call transcript: Teleflex Q1 2025 misses EPS forecast, stock dips - Investing.com India
Teleflex Fiscal Q1 Earnings, Revenue Decline; Lowers 2025 Guidance - marketscreener.com
Here's What Key Metrics Tell Us About Teleflex (TFX) Q1 Earnings - Yahoo Finance
Teleflex Q1 2025 slides: Revenue declines 3.8%, company lowers EPS guidance - Investing.com Australia
Teleflex (TFX) Reports Q1 Revenue Exceeding Expectations and Exp - GuruFocus
Teleflex (TFX) Tops Q1 Earnings and Revenue Estimates - Yahoo
Teleflex Raises Revenue Outlook Amid Q1 Revenue Decline - TipRanks
Teleflex Incorporated Stock (TFX) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.40%
0.78%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):